Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2\/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol - Fragoso-Saavedra_2020_BMC.Infect.Dis_20_765 |
| Author(s) : Fragoso-Saavedra S , Iruegas-Nunez DA , Quintero-Villegas A , Garcia-Gonzalez HB , Nunez I , Carbajal-Morelos SL , Audelo-Cruz BM , Arias-Martinez S , Caro-Vega Y , Calva JJ , Luqueno-Martinez V , Gonzalez-Duarte A , Crabtree-Ramirez B , Crispin JC , Sierra-Madero J , Belaunzaran-Zamudio PF , Valdes-Ferrer SI |
| Ref : BMC Infect Dis , 20 :765 , 2020 |
| Abstract : Fragoso-Saavedra_2020_BMC.Infect.Dis_20_765 |
| ESTHER : Fragoso-Saavedra_2020_BMC.Infect.Dis_20_765 |
| PubMedSearch : Fragoso-Saavedra_2020_BMC.Infect.Dis_20_765 |
| PubMedID: 33066761 |